Increased intestinal permeability, measured by serum zonulin, is associated with metabolic risk markers in overweight pregnant women.
暂无分享,去创建一个
[1] T. Rönnemaa,et al. Gut Microbiota Richness and Composition and Dietary Intake of Overweight Pregnant Women Are Related to Serum Zonulin Concentration, a Marker for Intestinal Permeability. , 2016, The Journal of nutrition.
[2] P. Møller,et al. Gut microbiota‐derived lipopolysaccharide uptake and trafficking to adipose tissue: implications for inflammation and obesity , 2016, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[3] K. Nicolaides,et al. First trimester screening for gestational diabetes mellitus by maternal factors and markers of inflammation. , 2016, Metabolism: clinical and experimental.
[4] M. Connelly,et al. GlycA, a marker of acute phase glycoproteins, and the risk of incident type 2 diabetes mellitus: PREVEND study. , 2016, Clinica chimica acta; international journal of clinical chemistry.
[5] S. Erkaya,et al. Prediction of gestational diabetes mellitus in the first trimester: comparison of C-reactive protein, fasting plasma glucose, insulin and insulin sensitivity indices , 2015, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[6] Liam G. Fearnley,et al. The Biomarker GlycA Is Associated with Chronic Inflammation and Predicts Long-Term Risk of Severe Infection. , 2015, Cell systems.
[7] S. Ozanne,et al. The effect of maternal Inflammation on foetal programming of metabolic disease , 2015, Acta physiologica.
[8] T. Powell,et al. Inflammation in maternal obesity and gestational diabetes mellitus. , 2015, Placenta.
[9] M. Connelly,et al. GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation. , 2015, Clinical chemistry.
[10] Pasi Soininen,et al. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. , 2015, Circulation. Cardiovascular genetics.
[11] F. Yue,et al. Serum zonulin is elevated in women with polycystic ovary syndrome and correlates with insulin resistance and severity of anovulation. , 2014, European journal of endocrinology.
[12] V. Salomaa,et al. Endotoxemia, nutrition, and cardiometabolic disorders , 2015, Acta Diabetologica.
[13] L. Pacifico,et al. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease. , 2014, World journal of gastroenterology.
[14] K. Porter,et al. Longitudinal changes in serum proinflammatory markers across pregnancy and postpartum: effects of maternal body mass index. , 2014, Cytokine.
[15] F. Yue,et al. Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patients. , 2014, Diabetes research and clinical practice.
[16] P. Ridker,et al. A Novel Protein Glycan Biomarker and Future Cardiovascular Disease Events , 2014, Journal of the American Heart Association.
[17] A. Maged,et al. Comparative study between different biomarkers for early prediction of gestational diabetes mellitus , 2014, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[18] Haitao Wen,et al. Inflammasomes and metabolic disorders: old genes in modern diseases. , 2014, Molecular cell.
[19] H. Uh,et al. Total plasma N-glycome changes during pregnancy. , 2014, Journal of proteome research.
[20] Stephen Wan,et al. Total adiponectin, but not inflammatory markers C-reactive protein, tumor necrosis factor-α, interluekin-6 and monocyte chemoattractant protein-1, correlates with increasing glucose intolerance in pregnant Chinese–Americans , 2014, Journal of diabetes.
[21] V. Mohan,et al. Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes , 2014, Molecular and Cellular Biochemistry.
[22] P. Ridker,et al. Abstract 18807: Novel Protein Glycan Derived Biomarker is Associated With Incident Diabetes , 2013 .
[23] J. Chudek,et al. Gut Microbiota, Microinflammation, Metabolic Profile, and Zonulin Concentration in Obese and Normal Weight Subjects , 2013, International journal of endocrinology.
[24] T. Henriksen,et al. Adiposity‐related inflammation: Effects of pregnancy , 2013, Obesity.
[25] Zhi‐hua Liu,et al. The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: a double-center and double-blind randomized clinical trial. , 2013, The American journal of clinical nutrition.
[26] W. Bao,et al. Inflammatory Markers and Risk of Type 2 Diabetes , 2012, Diabetes Care.
[27] J. Moreno-Navarrete,et al. Circulating Zonulin, a Marker of Intestinal Permeability, Is Increased in Association with Obesity-Associated Insulin Resistance , 2012, PloS one.
[28] R. Alfenas,et al. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia , 2012, British Journal of Nutrition.
[29] R. Zakaria,et al. Arterial stiffness, inflammatory and pro-atherogenic markers in gestational diabetes mellitus. , 2012, VASA. Zeitschrift fur Gefasskrankheiten.
[30] K. Clément,et al. Dietary factors and low-grade inflammation in relation to overweight and obesity , 2011, British Journal of Nutrition.
[31] S. Hauguel-de Mouzon,et al. Pregravid Obesity Associates With Increased Maternal Endotoxemia and Metabolic Inflammation , 2011, Obesity.
[32] P. Ebeling,et al. Decreased variation of inflammatory markers in gestational diabetes , 2011, Diabetes/metabolism research and reviews.
[33] G. Kac,et al. C-reactive protein and hormones but not IL-6 are associated to body mass index in first trimester of pregnancy , 2011, Archives of Gynecology and Obstetrics.
[34] F. Bäckhed,et al. The endocannabinoid system links gut microbiota to adipogenesis , 2010, Molecular systems biology.
[35] S. Ghavami,et al. Serum trypsin inhibitory capacity in normal pregnancy and gestational diabetes mellitus. , 2009, Diabetes research and clinical practice.
[36] L. Hansson,et al. Reference values for α1‐acid glycoprotein, α1‐antitrypsin, albumin, haptoglobin, C‐reactive protein, IgA, IgG and IgM during pregnancy , 2008, Acta obstetricia et gynecologica Scandinavica.
[37] R. Bibiloni,et al. Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice , 2008, Diabetes.
[38] P. Catalano,et al. Metabolic changes in pregnancy. , 2007, Clinical obstetrics and gynecology.
[39] Dario Iafusco,et al. Zonulin Upregulation Is Associated With Increased Gut Permeability in Subjects With Type 1 Diabetes and Their Relatives , 2006, Diabetes.
[40] T. Forst,et al. High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. , 2006, Diabetes technology & therapeutics.
[41] C. Lopes,et al. Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome , 2005, International Journal of Obesity.
[42] Ralph B D'Agostino,et al. Trends in cardiovascular complications of diabetes. , 2004, JAMA.
[43] Paul M Ridker,et al. C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke , 2003, Circulation.
[44] B. Zinman,et al. C-reactive protein and gestational diabetes: the central role of maternal obesity. , 2003, The Journal of clinical endocrinology and metabolism.
[45] Gary L Myers,et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.
[46] D A Follmann,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans , 2022 .
[47] M. A. Lasunción,et al. Longitudinal study on lipoprotein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women. , 1996, Journal of lipid research.
[48] Y. Omori,et al. Quantitative analysis of serum α1-acid glycoprotein levels in normal and diabetic pregnancy , 1990 .
[49] Y. Omori,et al. Quantitative analysis of serum alpha 1-acid glycoprotein levels in normal and diabetic pregnancy. , 1990, Diabetes research and clinical practice.
[50] C. Chu,et al. Plasma α1-acid glycoprotein levels in pregnancy , 1981 .
[51] H. P. Wang,et al. Plasma alpha 1-acid glycoprotein levels in pregnancy. , 1981, Clinica chimica acta; international journal of clinical chemistry.